TJ-M-2010-5 | Interleukin Related interleukin-related.com

Product Name :
TJ-M-2010-5

Search keywords :
TJ-M2010-5

drugId :
null

Target Vo:
Myeloid differentiation primary response protein MyD88

Target Vo Short Name :
MYD88

Moa_Name:
Myeloid differentiation primary response protein MyD88 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Tongji Medical College

Active Company_Name :
Tongji Medical College

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SQSTM1/p62 Rabbit mAb site
8-OHdG (DNA/RNA Damage) Antibody medchemexpress
c-Jun Antibody: c-Jun Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to c-Jun. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts